Imperial College London

DrJohannaRhodes

Faculty of MedicineSchool of Public Health

Honorary Research Fellow
 
 
 
//

Contact

 

johanna.rhodes

 
 
//

Location

 

Desk 17Sir Michael Uren HubWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Rhodes:2019:10.1016/j.mib.2019.05.008,
author = {Rhodes, J and Fisher, MC},
doi = {10.1016/j.mib.2019.05.008},
journal = {Current Opinion in Microbiology},
pages = {84--89},
title = {Global epidemiology of emerging Candida auris},
url = {http://dx.doi.org/10.1016/j.mib.2019.05.008},
volume = {52},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The discovery in 2009 of a new species of yeast, Candida auris, heralded the arrival of a novel emerging human infectious disease. This review highlights the unique characteristics of C. auris that have lled to it being of public health concern worldwide, namely public health concern, namely its global emergence, its ability to cause nosocomial outbreaks in healthcare settings, its innate and emerging resistance to multiple antifungal drugs and its resilience in the face of hygiene and infection control measures. Genomic epidemiology has identified four emergences of C. auris marked by four clades of the pathogen. These clades of C. auris are genetically dissimilar and are associated with differential resistance to antifungal drugs, suggesting that they will continue to phenotypically diverge into the future. The global emergence of C. auris testifies to the unmapped nature of Kingdom Fungi, and represents a new nosocomial threat that will require enhanced infection control across diverse healthcare and community settings.
AU - Rhodes,J
AU - Fisher,MC
DO - 10.1016/j.mib.2019.05.008
EP - 89
PY - 2019///
SN - 1369-5274
SP - 84
TI - Global epidemiology of emerging Candida auris
T2 - Current Opinion in Microbiology
UR - http://dx.doi.org/10.1016/j.mib.2019.05.008
UR - http://hdl.handle.net/10044/1/71329
VL - 52
ER -